Encequidar (mesylate)
Encequidar mesylate (HM30181 mesylate; HM30181A mesylate) is a competitive and potent P-glycoprotein inhibitor.
Product Specifications
CAS Number
849675-87-2
Product Name Alternative
HM30181 (mesylate) ; HM30181A (mesylate)
UNSPSC
12352005
Hazard Statement
H317, H335
Target
P-glycoprotein
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/HM30181_mesylate.html
Purity
99.82
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C2=CC=CC=C2O1)=O)NC3=CC(OC)=C(OC)C=C3C4=NN(C5=CC=C(CCN6CC7=C(C=C(OC)C(OC)=C7)CC6)C=C5)N=N4.CS(=O)(O)=O
Molecular Formula
C39H40N6O10S
Molecular Weight
784.83
Precautions
H317, H335
References & Citations
[1]Kim JC, et al. Effect of HM30181 mesylate salt-loaded microcapsules on the oral absorption of NSC 125973 as a novel P-glycoprotein inhibitor. Int J Pharm. 2016 Jun 15;506 (1-2) :93-101.|[2]Joo KM, et al. Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors. Int J Oncol. 2008 Oct;33 (4) :705-12.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742752-500 1x 500 µL
Heregulin-1 / Neuregulin-1 (Breast and Urothelial Marker) (NRG1/2752), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
